5 - 7 December 2019 International Convention Centre (ICC) Sydney

International Faculty Members Include

Gary Ansel
Gary Ansel

System Medical Chief, Vascular Program – OhioHealth, and Assistant Clinical Professor of Medicine in the Department of Internal Medicine at the University of Toledo Medical Center, Toledo, Ohio, USA.

Gary is an internationally renowned interventional expert, both in peripheral vascular and cardiovascular procedures. An expert in his field, he continues to teach and share his knowledge with physicians in the US as well as in China, Japan, England, Ireland, Germany, Italy, Australia, and New Zealand, to name a few, as well as a primary investigator and a national primary investigator for numerous research trials, enabling him to provide cutting-edge technology and the best patient care available to those suffering with peripheral and cardiovascular disease.

He continues to serve as a member of several professional societies, is a former member of the Peripheral Vascular Committee for the American College of Cardiology, and contributes to a number of journals as well as having authored many medical book chapters.

Sven Braunlich
Sven Braunlich

Senior Consultant, Division of Interventional Angiology, University Hospital, Leipzig, Germany

Sven has been working with Dierk Scheinert since 2002. His focus is on state-of-the-art interventional therapy of all kinds of PAOD, especially lower extremeties, CTO’s, CLI and BTK in a high volume centre with more than 4000 interventions per year. His other interest is on all modalities of aortic repair, carotid artery stenting, renal artery stenting and denervation, as well as novel treatment options like drug eluting technology and atherectomy.

He has been a co-organiser of LINC, which now sees 5000 attending from more than 80 countries, and is a member of the faculty and co-organiser of LAP – LINC Asia-Pacific in Hong Kong. He is a live case operator and faculty at leading medical conferences, including LINC, LINC Asia-Pacific, VERVE, VIVA, TCT, NCVH, Cirse, and Charing Cross.

Marianne Brodmann
Marianne Brodmann

Vascular Specialist, Division of Angiology, Medical University, Graz Austria

Since 2013 Marianne has been a member of the nucleus of the European Society of Vascular Medicine, is a longstanding member of the UEMS Board of Angiology and was President of the ÖGIA (Austrian Society of Angiology) from 2012 to 2014. Her research interests include anticoagulation and thrombolysis; new endovascular technologies in the peripheral field; and evaluation of nature of restenosis and has participated in 50 international clinical trials. She was President of the Working Group Peripheral Circulation of the European Society of Cardiology from 2014 to 2016.

Frank Criado
Frank Criado

Vascular Surgeon and Endovascular Specialist, MedStar Union Memorial Hospital in Baltimore, Maryland USA.

Frank is widely recognised to be a pioneer in endovascular therapy, and a major presence at most major vascular and endovascular congresses and events in the U.S. and around the world. He has contributed extensively to the literature with more than 170 papers, editorials, and book chapters. He was the Editor-in-Chief of Vascular Disease Management (VDM) from its inception in 2004 until the end of 2013. He has also been very active in clinical research, with a major focus on aortic stent-graft and carotid interventions, and endovascular technologies in general. He was the U.S. National Principal Investigator (P.I.) for the Medtronic Talent AAA clinical trials, and a member of the Executive Committee for the Medtronic Valor and Valor II Thoracic TAA trials. Additionally, he has been a Site-Principal Investigator for multiple other clinical studies testing aortic endografts and carotid-stent systems.

Rick De Graaf
Rick De Graaf

Director Clinic for Diagnostic and Interventional Radiology/Nuclear Medicine Clinical Center of Friedrichshafen Germany

Rick has been Chief of Radiology, Interventional Radiology and Nuclear Medicine since 2018, and is Coordinating Director of Vascular Medicine at the Clinical Centre of Friedrichshafen, Germany.

After clinical and research fellowships at renowned international institutes (Montefiore Medical Centre, dr. Frank Veith, NYC and Prof. Rene Chapot, Alfred Krupp Clinic, Essen), he focused on the minimal invasive treatment of (neuro-) vascular diseases.

In 2010 he started the endovascular treatment of deep venous obstructions at the interventional Radiology Department in Maastricht. This has led to international collaboration with the University Hospital in Aachen and the Angiology Department of the Arnsberg Clinic, Germany. His venous dedication is illustrated by the numerous invited lectures and visiting scholarships. He has published widely and through his strong focus on venous interventions he has become a very well respected physician in the community.

Brian DeRubertis
Brian DeRubertis

Assoc Prof Brian DeRubertis UCLA Medical Centre Los Angeles USA

Following his vascular and endovascular surgery fellowship with the Division of Vascular Surgery of Cornell University and Columbia College of Physicians and Surgeons at New York Presbyterian Hospital, Brian joined the Division of Vascular Surgery at the David Geffen School of Medicine at UCLA in 2007, and is an attending surgeon at the UCLA Ronald Regan Medical Center and at the UCLA-Santa Monica Medical Center. His current surgical practice involves the application of the newest minimally invasive technology for the treatment of complex aortic aneurysms, peripheral arterial disease of the carotid arteries and lower extremities, and venous disorders including deep venous thrombosis, Paget-Schroetter’s Syndrome, and May-Thurner’s Syndrome. He has a particular interest in innovative device technology, and has introduced the practice of percutaneous EVAR and the use of fenestrated aortic endografts to his institution.

He is very active in clinical research on these topics and has presented widely at US and International Conferences. He has also co-authored 13 book chapters and more than 65 peer-reviewed publications in journals that include Surgery, the Journal of Vascular Surgery, Vascular and Endovascular Surgery, Archives of Surgery, Cancer Gene Therapy, and many others.

He is a national Co-Prinicipal investigator on the REALITY Trial, which evaluates the utility of atherectomy and drug-coated balloon angioplasty as a treatment for femoropopliteal disease in claudicants, and has participated in over a dozen clinical trials at UCLA, including the current NIH-funded BEST-CLI Trial for lower extremity revascularization. He is an active member of multiple surgical societies, including the Society for Vascular Surgery, the Western Vascular Society, the Pacific Coast Surgical Society, and the Vascular and Endovascular Surgery Society, among others, and has served as Co-Director of the Peripheral Vascular Course at the annual Transcatheter Therapeutics Conference.

Eric Ducasse
Eric Ducasse

Professor and Head Vascular Surgery Unit University Hospital of Bordeaux France

Eric’s unit covers emergency and traumatic general surgery. It is the largest unit in the south west of France involving 7 senior surgeons, 4 post graduates and 8 trainees. He is especially implicated in the treatment of AAA, TAA and PAD including BTK treatment, as well as his bilateral focus on clinical practice, training and teaching for the specialist in France. His main practice is dedicated to endovascular treatment and development.

Yann Goueffic
Yann Goueffic

Service de Chirurgie Vasculaire, Hopital Nord Laennec, Nantes France

Yann is the Professor and Chief of the Department of Vascular Surgery Service de Chirurgie Vasculaire, Hopital Nord Laennec, Nantes France. Since Sept 2007, he has also been the Senior University Lecturer and Hospital Practitioner in the Vascular Surgery Department at the University Hospital of Nantes.

He has extensive clinical studies experience, continues his research interests and has published widely.

Steve Henao
Steve Henao

Medical Director for Cardiovascular Research at the Heart Hospital of New Mexico.

Steve’s clinical interests include aortic therapy, carotid disease and critical limb ischemia.

He is currently involved in numerous clinical studies, two in particular where he was the highest enrolling clinician in the US. These are the LUCY study looking at the benefits of low profile aortic aneurysm therapy and how it relates to women, and the LIFE study, looking at minimally invasive anaesthesia and postoperative care in an aortic fast-track protocol.

He continues to improve patient care by utilizing contemporary technologies and evidence-based vascular practices for his patients throughout the Southwestern United States.

He has published widely, both with book chapters and journal articles and presents at conferences both within the US and internationally.

Peter Holt
Peter Holt

Professor of Vascular Surgery at St George’s Vascular Institute, London

Peter is the vascular network lead and head of department in this busy regional Vascular Surgical Unit that provides secondary and tertiary care to 1.5 million patients in South West London.

He has published over 250 peer-reviewed articles on all aspects of vascular disease, including both arterial and venous disorders. He manages a spectrum of clinical practice including focussing around complex aneurysm surgery, and peripheral arterial disease.

Peter holds and has held committee memberships on a number of national committees, including NICE appraisals and the Academy of the Medical Royal Colleges and currently leads a research programme focussing on population health research and health technology assessment.

Osamu Iida
Osamu Iida

Associate Director of the Cardiovascular Centre, Kansai Rosai Hospital, Japan

Osamu is an established and highly skilled physician with over seventeen years of experience. He has a great deal of experience in the endovascular treatment, specifically vessels of thoracic, abdominal and lower limbs with more than 1,000 cases per year. He also serves as the Chief of Coronary, Endovascular, and Structure Treatments. He was selected Best Doctors in Japan 2016-2017 by Teradoc, Inc.

As a researcher, he has published 35 original papers as a first author and co-authored more than 150 papers. His main research interests are clinical research of SFA treatment using IVUS, research about angiosome (CLI single-site study), various studies which impact many treatment strategies (CLI multicenter study).

Tilo Kölbel
Tilo Kölbel

Professor of Vascular Surgery at the University of Hamburg, Germany

Tilo trained as a general surgeon in Berlin, working as a fellow and later staff member in vascular surgery and interventional radiology at Malmö University Hospital in Sweden from 2004-2009. He then established endovascular therapies in the Department of Vascular Medicine with Prof. Sebastian Debus at the University Heart Centre Hamburg in 2009 and has been Head of the German Aortic Centre since 2012.

Today his main clinical and scientific interest lie in aortic disease with a focus on complex endovascular techniques, aortic dissection, aortic arch interventions and development of new endovascular treatment strategies and devices.

He is a member of a number of European societies and a reviewer for major North American, European and Asian vascular and interventional radiological journals and is an editorial board member of the Journal of Endovascular Therapy.

Luis Leon
Luis Leon

Vascular and Endovascular Surgeon, Tucson Medical Centre Northwest Medical Centre, Arizona USA

Leon serves as an active member of the Vascular and Endovascular Surgery Section at Tucson Medical Centre and at Northwest Medical Centre in Tucson, Arizona. He has also served as the Chief of Vascular Surgery at the Veterans Affairs Hospital in Tucson from 2005 until 2008 and, during his tenure there, belonged to several committees, including the Research and Development, Limb Preservation and Peer Review Committees.

His academic productivity has earned him a number of awards, including the Charles C Guthrie Award from the Midwestern Vascular Surgery Society in 2004 and the very prestigious E.J. Wylie Traveling Fellowship Award from the American Vascular Association in 2007.

His productivity also earned him an Associate Professor of Surgery degree at the University of Arizona, tenure-eligible, since April 2008. He has a strong interest in both the research and clinical aspects of carotid, aortic and venous disease.

Ross Milner
Ross Milner

Professor of Surgery, The University of Chicago, USA

Ross is a board-certified general and vascular surgeon. In addition, he is the Vice-Chair of Clinical and Peri-operative services and serves as Co-Directory for the Centre of Aortic Diseases. He is an internationally recognized expert in the treatment of complex aortic aneurysmal disease and endograft surveillance paradigms and has been a leader in training other physicians in these areas.

He has been the primary investigator on numerous endovascular device trials and currently serves as the co-national principal investigator for the GREAT registry.

A dedicated educator and mentor, Ross teaches medical students, residents, and fellows about vascular disease management, including the use of aortic stents. He has received numerous awards for his teaching and has been recognized as the first master clinician of the Bucksbaum Institute for Clinical Excellence at the University of Chicago. He is also a reviewer for many journals and is an editorial board member for Endovascular Today and Vascular Disease Management.

Jihad Mustapha
Jihad Mustapha

Director of Cardiovascular Catheterization Laboratories, Director of Endovascular Interventions and Director of Cardiovascular Research at Metro Health Hospital – Metro Heart and Vascular in Wyoming Michigan.

As a board-certified interventional cardiologist, he specializes in minimally invasive, non-surgical therapy for heart and peripheral vascular disease. He has advanced training in coronary stent and complex peripheral vascular disease treatments including laser, atherectomy, and totally occluded arteries. He is the Founder and Director of the AMPutation Prevention Symposium (AMP), has multiple publications, including those on critical limb ischemia and amputation prevention.

Tatsuya Nakama
Tatsuya Nakama

Chief Physician, Department of Cardiology, Tokyo Bay Uravasu Ishikawa Medical Centre, Japan

Tatsuya moved from Chief of Cathererization Laboratory, Department of Cardiology at the Miyazaki Medical Association Hospital in 2018 to his new position as Chief Physician in the Department of Cardiology at the Tokyo Bay Uravasu Ichikawa Medical Centre.

He has published widely, participated in numerous conferences and is a member of many LINC faculties.

Mahmood Razavi
Mahmood Razavi

Director of the Center for Clinical Trials and Research at St Joseph Heart and Vascular Center in Orange, California

Mahmood has had two subspeciality fellowship trainings at Stanford Unversity and UCLA and has continued to be associated with the University in Vascular and Interventional Radiology.

He is considered ot be an authority in the field of minimally invasive therapies and has published and authored widely as well as being the recipient of many honors and awards from various professional medical societies. Mahmood has served as the Editor and on the Editorial Boards of several prestigious scientific journals and his scientific work has featured in over 100 national and international radio, television and press news articles and programs.

Hei is the co-founder of five start-up companies and has served on the Board of Directors and the Scientific and strategic Advisory Boards of several device and biotechnology companies.

Kenneth Rosenfield
Kenneth Rosenfield

Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital USA

Ken is an interventional cardiologist and vascular specialist performed complex cardiac and vascular interventions. In addition, he has dedicated much of his career to educating fellows, residents, students, and colleagues. He is the recipient of the distinguished Laennec award for his outstanding teaching and mentorship and is also a researcher and clinical trialist. He designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial.

Ken is a leader in the cardiovascular world, having been elected to the Board of Governors of American College of Cardiology, immediate past-President of the MA ACC Chapter, immediate past-President of the Society for Cardiovascular Angiography and Interventions (SCAI), a founding member of VIVA.

At Massachusetts General Hospital, he is the Medical Director of the PERT Program, which he founded with his colleagues; as well as having founded and served as its initial President, the National PERT Consortium, a 501c3 organization dedicated to improving management, outcomes, and awareness of Pulmonary Embolism. He has recently developed an innovative Balloon Pulmonary Angioplasty (BPA) program for patients with CTEPH at MGH, and is collaborating to develop a national initiative and database for these procedures.

Marc Schermerhorn
Marc Schermerhorn

Chief of the Division of Vascular and Endovascular Surgery at Beth Israel Deaconess Medical Centre and the George H A Clowes Jr Professor of Surgery at Harvard Medical School USA

Marc is an international leader in the field of clinical effectiveness research with a particular focus on the impact of new endovascular therapies on aortic aneurysm repair which supports his clinical interest in complex aortic surgery and intervention.

He is President Elect of the New England Society for Vascular Surgery and a Distinguished Fellow of the Society for Vascular Surgery. He is a member of the European Society for Vascular Surgery, American College of Surgeons, and American Heart Association and serves as a member of the Medical Devices Advisory Panel for the FDA and consultant for the Agency for Healthcare Research and Quality. He is a member of three editorial boards and a reviewer for 13 other major journals. In addition, he has an NIH funded lab, has authored peer-reviewed articles, case reports, book chapters and reviews, including original manuscripts in the New England Journal of Medicine, and the Journal of the American Medical Association. He has lectured at many national and international forums. He is mentor to numerous surgical residents interested in pursuing careers as clinical investigators

Peter Schneider
Peter Schneider

Chief of Vascular Therapy, Kaiser Foundation Hospital in Honolulu, Hawaii

Peter practices in Honolulu and has a strong interest in education and training in vascular and endovascular techniques. He has been in practice for 23 years and is Chief of Vascular Therapy at Kaiser Foundation Hospital in Honolulu and has worked with many residents and fellows. He attended Johns Hopkins School of Medicine and then University of California San Francisco for general and vascular surgery training.

He has served on many committees for the Society for Vascular Surgery and the Western Vascular Society, been invited to many visiting professorships, and served as Faculty or Course Director for specialty courses. He authored Endovascular Skills, now in its 3rd edition, and co-authored two other vascular books.

He is currently President of the Western Vascular Society and VIVA. Roles within the Kaiser organization have included Board of Directors and Chief Financial Officer.

Darren Schneider
Darren Schneider

Chief of Vascular and Endovascular Surgery, Weill Cornell Medical College New York USA

Darren Schneider is an internationally recognized expert in advanced minimally invasive treatment for vascular disease. He is a pioneer in the development and application of innovative endovascular techniques for the treatment of carotid disease, aortic aneurysms, and peripheral artery disease. His clinical research is focused on the design and development of endovascular devices for the treatment of patients with these conditions, and he is an investigator in numerous national and international clinical trials. Currently he is the lead-investigator of a single-center IDE study at the NewYork-Presbyterian/Weill Cornell Medical Center evaluating the use of branched and fenestrated aortic stent grafts to treat thoracoabdominal aortic aneurysms. He is also the national principal investigator of a multicenter study of endovascular iliac artery aneurysm repair using branched stent grafts.

His other appointments are Program Director in Vascular Surgery at NewYork-Presbyterian Hospital, and Co-Executive Director of the Vascular Service Line at NewYork-Presbyterian Hospital USA.

Jos Van den Berg
Jos Van den Berg

Head of the Department of Radiology, St. Antonius Hospital, The Netherlands

Jos’ main interest is in interventional and vascular radiology. He successfully defended his thesis entitled “Groin hernia: the role of diagnostic imaging” dealing with the role of Magnetic Resonance Imaging in the diagnosis of groin hernia in April 2001. Since July 2001 he has been the Head of the Department of Radiology of the St. Antonius Hospital and is also Head of the Service of Interventional Radiology in the Ospedale Regionale di Lugano, Switzerland, is Associate Professor of Radiology (Privat Dozent), as well as a lecturer in the Medical Faculty at the University of Bern. Jos is also Associate Professor of Vascular Surgery at the University of Pisa, Italy.

He is a past-president of the Dutch Endovascular Forum, is an active member of the Dutch Society of Radiology (Nederlandse Vereniging voor Radiologie), the ECR (European Congress of Radiology), CIRSE (Cardiovascular and Interventional Radiological Society of Europe) and the SSCVIR (Swiss Society of Cardiovascular and Interventional Radiology), Jos is a reviewer for a number of vascular and interventional radiology journals.

Hence Verhagen
Hence Verhagen

Professor and Chief of Vascular Surgery Erasmus University Medical Center Rotterdam, The Netherlands.

A major part of his vascular fellowship was undertaken at the Department of Vascular Surgery at The Royal Prince Alfred Hospital in Sydney where he developed his special interest in minimal-invasive endovascular therapies and, in particular, endovascular aneurysm treatment.

As an early adapter of advanced endovascular therapies, he became an internationally renowned expert in this field. He has organized many basic-, and advanced international training courses on EVAR and TEVAR and is the founder of the Dutch practical course (basic and advanced) on peripheral percutaneous vascular interventions for Vascular Surgeons in which he still participates as convenor. He has performed several “first in Man” implantations of aortic endografts and is global Principal Investigator (PI) of several Aortic Stentgrafts.

He has a special interest in Aortic pathology and interventions, including cutting-edge endovascular technologies. He has specific expertise in carotid surgery, chronic bowel ischaemia, peripheral interventions and vascular imaging (dynamic, peri-operative and post-processing). He has published widely and is a member of many international vascular societies.

Eric Verhoeven
Eric Verhoeven

Chief of Vascular and Endovascular Surgery, Department of Vascular Surgery, Germany

In January 2011, Eric was awarded a guest-professorship of Surgery at the University of Lisbon, Portugal, and in October that year he accepted a Professorship in Vascular Surgery at the University of Leuven, Belgium. In 2014, he became full professor in vascular surgery at the Paracelsus Medical University of Nuremberg.

His main interest, both clinical and scientific, continues to be the treatment of complex aortic aneurysms with fenestrated and branched grafts, with now experience in more than 1200 cases.